PrescriptionDrugs.org

Pravastatin

Key Takeaway

Pravastatin is a hydrophilic statin used to lower LDL cholesterol and reduce cardiovascular risk. It has fewer drug interactions than most statins because it is not significantly metabolized by CYP3A4. The WOSCOPS trial demonstrated that pravastatin reduces cardiovascular events in primary prevention.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

How does Pravastatin work?

Like all statins, pravastatin works by blocking an enzyme called HMG-CoA reductase in the liver [1, 2]. This enzyme controls a key step in cholesterol production. When it is blocked:

1. The liver produces less cholesterol [1, 2] 2. The liver compensates by pulling more LDL ("bad") cholesterol from the bloodstream by increasing LDL receptor expression on liver cells [1, 3] 3. Blood LDL cholesterol drops by approximately 20-35% depending on the dose

Pravastatin is classified as a low-to-moderate intensity statin [3, 4]. Unlike atorvastatin and rosuvastatin (high-intensity statins), pravastatin produces a more modest LDL reduction.

However, pravastatin has a notable advantage: it is hydrophilic (water-soluble) rather than lipophilic [1, 2, 5]. This means: - It is taken up primarily by the liver (its target organ) rather than distributing widely into muscle and other tissues - It may have a lower risk of muscle-related side effects compared to lipophilic statins, though this remains debated [5] - It is not metabolized by CYP3A4 [1, 2], resulting in fewer drug interactions than simvastatin, atorvastatin, or lovastatin

Landmark trials established pravastatin's cardiovascular benefits: WOSCOPS (primary prevention — 31% reduction in coronary events) [6], CARE (post-MI — 24% reduction in coronary events) [7], and LIPID (post-ACS — 24% reduction in coronary mortality) [8].

What to expect when starting Pravastatin

When starting pravastatin [1, 2]:

First few days: Most patients notice no immediate effects. Statins work gradually — you will not feel the cholesterol lowering.

First 2-4 weeks: Your doctor may check a lipid panel after 4-6 weeks to assess the response. LDL cholesterol typically decreases by 20-30%.

Muscle effects: While muscle pain (myalgia) can occur with any statin, pravastatin may be better tolerated than some lipophilic statins. If you develop unexplained muscle pain, tenderness, or weakness, report it to your doctor.

Evening dosing [1]: Pravastatin is usually taken in the evening because cholesterol synthesis peaks at night. However, due to its relatively short half-life, consistent daily dosing is more important than the exact time.

Ongoing: Statin therapy is typically lifelong. Continue taking pravastatin even when your cholesterol reaches goal — stopping the medication will cause cholesterol to rise again.

What are the common side effects of Pravastatin?

Common

Common(9 effects)
  • Headache2-6%
  • Nausea/GI upset3-7%
  • Diarrhea3-6%
  • Myalgia (muscle pain)2-4%
  • Fatigue2-4%
  • Dizziness1-3%
  • Rash1-4%
  • Heartburn1-3%
  • Elevated liver enzymes1-2%

What are the serious side effects of Pravastatin?

Serious

Common(1 effect)
  • New-onset diabetesSmall increase (9-12% relative risk increase)
Serious(3 effects)
  • Myopathy (CK >10x ULN with symptoms)Rare (<0.1%)
  • Hepatotoxicity (significant ALT elevation)<1%
  • Immune-mediated necrotizing myopathyVery rare
Life-Threatening(1 effect)
  • RhabdomyolysisVery rare (<0.01%)

What drugs interact with Pravastatin?

  • Major
    Cyclosporine Cyclosporine increases pravastatin levels approximately 5-10 fold via OATP1B1 inhibition. Limit pravastatin to 20 mg/day with cyclosporine.
  • Moderate
    Clarithromycin, erythromycin May increase pravastatin levels via OATP1B1 inhibition (not CYP3A4). Monitor for muscle symptoms.
  • Major
    Gemfibrozil Increases statin levels and myopathy risk via OATP1B1 inhibition and glucuronidation inhibition. Avoid combination.
  • Moderate
    Niacin (>1 g/day) Additive myopathy risk. Use combination with caution and monitor for muscle symptoms.
  • Moderate
    Colchicine Increased myopathy risk when combined with statins. Monitor for muscle symptoms.
  • Moderate
    Warfarin Pravastatin may modestly increase INR. Monitor INR when starting, stopping, or changing pravastatin dose.

View all drug interactions →

Can I eat certain foods or drink alcohol with Pravastatin?

Food [1]: Pravastatin can be taken with or without food. Food reduces absorption somewhat but does not significantly affect LDL lowering. Take it consistently.

Alcohol [1]: Excessive alcohol consumption increases the risk of liver damage when combined with statins. Moderate alcohol consumption (1 drink/day for women, 2 for men) is generally acceptable. Heavy drinkers should discuss statin use with their doctor.

Grapefruit: Pravastatin is not metabolized by CYP3A4 and does not have a significant grapefruit interaction [1, 2, 5]. This is a major advantage over simvastatin, atorvastatin, and lovastatin. Patients on pravastatin can consume grapefruit freely.

Fiber supplements: Cholestyramine and other bile acid sequestrants should be taken at least 1 hour before or 4 hours after pravastatin to avoid reduced absorption [1].

What is the typical dosage for Pravastatin?

Primary hypercholesterolemia and mixed dyslipidemia [1, 2]: - Adults: Start 40 mg once daily. Range: 10-80 mg once daily - Maximum: 80 mg/day - Usual effective dose: 40 mg/day

Cardiovascular risk reduction [1, 6, 7]: - 40 mg once daily (dose used in WOSCOPS, CARE, and LIPID trials)

Pediatric (ages 8-13) [1]: - 20 mg once daily

Pediatric (ages 14-18) [1]: - 40 mg once daily

Renal impairment [1]: Start at 10 mg daily in patients with significant renal impairment (CrCl <60 mL/min, including dialysis).

Hepatic impairment [1]: Use with caution. Monitor liver function.

With cyclosporine [1]: Limit to 20 mg daily.

Timing: Usually taken in the evening, but can be taken at any time. Consistent daily administration is most important.

How much does Pravastatin cost?

Generic pravastatin is widely available and very affordable [9, 10].

Pricing comparison [9, 10]: - Generic pravastatin: $5-15/month - Brand Pravachol: $150-300/month (rarely prescribed) - Available on $4 generic programs at most pharmacies

Insurance coverage: Generic pravastatin is Tier 1 on virtually all formularies [10].

Cost comparison with other statins: - Pravastatin 40 mg and simvastatin 40 mg are similarly priced (both very affordable) - Generic atorvastatin is also inexpensive and more potent - Choice depends on required LDL lowering intensity, drug interactions, and tolerability

Cost-saving tip: Pravastatin is one of the least expensive cardiovascular medications available. If cost is the primary concern, generic pravastatin or simvastatin are excellent options.

Is Pravastatin safe during pregnancy or breastfeeding?

Pregnancy [1]: Pravastatin is contraindicated in pregnancy. All statins carry warnings against use during pregnancy. Cholesterol is essential for fetal development, and inhibiting cholesterol synthesis may cause birth defects.

Discontinue pravastatin at least 1 month before attempting to conceive if possible. If pregnancy is discovered during therapy, discontinue immediately [1].

Note: Some recent research has explored pravastatin specifically for prevention of preeclampsia (due to its hydrophilic properties and potential placental benefit), but this remains investigational and is not an approved use.

Breastfeeding [1, 11]: A small amount of pravastatin is excreted in breast milk. Because of the potential disruption to infant lipid metabolism, pravastatin is contraindicated during breastfeeding [1].

Is there a generic version of Pravastatin?

Generic pravastatin has been available since 2006 [9, 10].

Available generic formulations: - Pravastatin sodium tablets: 10, 20, 40, 80 mg — equivalent to Pravachol - All generics are AB-rated by the FDA [9]

Brand vs. generic: No clinically meaningful differences.

Key advantage of pravastatin over other statins: It is not metabolized by CYP3A4, so patients who need to take CYP3A4 inhibitors (verapamil, diltiazem, amiodarone, certain antifungals, certain antibiotics) or who eat grapefruit regularly may benefit from pravastatin rather than simvastatin or atorvastatin.

For Caregivers

Muscle symptom awareness [1, 2]: While pravastatin is generally well tolerated, any unexplained muscle pain, tenderness, or weakness should be reported to the doctor. If symptoms are severe, a blood test (CK level) may be needed to rule out serious muscle damage (rhabdomyolysis).

Medication adherence [3, 6]: Statin therapy is lifelong for most patients. Help the patient understand that even though they feel fine, the statin is actively preventing heart attacks and strokes. Stopping the medication will cause cholesterol to rise again.

Evening dosing [1]: Pravastatin is typically taken in the evening. Help establish a consistent daily routine.

Lab monitoring [1]: A lipid panel is usually checked 4-6 weeks after starting or changing the dose. Liver function tests may be checked periodically, though routine monitoring is no longer universally recommended for all statin users.

Frequently asked questions about Pravastatin

References

  1. [Regulatory] Pravachol (pravastatin sodium) FDA Prescribing Information. Bristol-Myers Squibb. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019898s075lbl.pdf Accessed 2026-02-15.
  2. [Regulatory] DailyMed - Pravastatin sodium tablet label and package insert. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1d26dd34-c7e1-4b52-a16f-89b7ec61ad77 Accessed 2026-02-15.
  3. [Observational] Grundy SM, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. J Am Coll Cardiol. 2019;73(24):e285-e350. https://pubmed.ncbi.nlm.nih.gov/30423393/ Accessed 2026-02-15.
  4. [Observational] Whelton PK, et al. 2017 ACC/AHA Guideline for Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/ Accessed 2026-02-15.
  5. [Clinical] Schachter M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol. 2005;19(1):117-125. https://pubmed.ncbi.nlm.nih.gov/15660968/ Accessed 2026-02-15.
  6. [Clinical] Shepherd J, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia (WOSCOPS). N Engl J Med. 1995;333(20):1301-1307. https://pubmed.ncbi.nlm.nih.gov/7566020/ Accessed 2026-02-15.
  7. [Clinical] Sacks FM, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels (CARE). N Engl J Med. 1996;335(14):1001-1009. https://pubmed.ncbi.nlm.nih.gov/8801446/ Accessed 2026-02-15.
  8. [Clinical] The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease. N Engl J Med. 1998;339(19):1349-1357. https://pubmed.ncbi.nlm.nih.gov/9841303/ Accessed 2026-02-15.
  9. [Regulatory] FDA Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations — Pravastatin. https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book Accessed 2026-02-15.
  10. [Regulatory] MedlinePlus: Pravastatin. https://medlineplus.gov/druginfo/meds/a692025.html Accessed 2026-02-15.
  11. [Regulatory] Drugs and Lactation Database (LactMed) — Pravastatin. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK501151/ Accessed 2026-02-15.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: